Cite

HARVARD Citation

    Dubinsky, M. et al. (2018). Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases. 24 (9), pp. 1876-1882. [Online]. 
  
Back to record